Patients
- Upload Prescription
- Request A Call Back
- Book A Test
- Download Report
- TRF For COVID-19
- Feedback
| Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
|---|
₹ 3200
| EX1667 OVARIAN CANCER PANEL | |||||||
| Specimen: | 4 mL ( 2 mL min.) serum from 1 SST. Ship refrigerated or frozen. | ||||||
| Stability: |
|
||||||
| Method: | CMIA, EIA | ||||||
| Comment: | |||||||
| Report: | Contact us to know the TAT. | ||||||
| Usage: | Ovarian cancer is classified into three types: Epithelial (80%), Germ cell tumor (10-15%) & Stromal sex cord tumors (5-10%). Epithelial ovarian tumors are further subdivided into serious (70%), mucinous(10-15%), and endometroid (10-15%). Granulosa cell tumors represent the majority of the Stromal sex cord tumor. CA 125 is elevated in 50% of patients with stage I ovarian cancer, 90% with stage II and > 90% in stage III & IV. CA 125 is not a good tumor marker for Mucinous & Granulosa cell tumors. Inhibin B is a useful tumor marker for these two malignancies. Inhibin B elevation has been reported in 89-100% of patients with Granulosa cell tumors & 55-60% of patients with Mucinous Epithelial tumors. | ||||||
| Doctor Specialty: | Oncologist | ||||||
| Disease: | Cancer | ||||||
| Components: | *CA 125 *Inhibin B | ||||||
| Courier Charges: | 0.00 | ||||||
| Home Collection: | Available (*T&C Apply) | ||||||
| Department: | Biochemistry | ||||||
| Pre Test Information: | No special preparation required | ||||||
a division of exult cares pvt. ltd.
Reviews
There are no reviews yet.